» Articles » PMID: 20110884

Screening and Improvement of an Anti-VEGF DNA Aptamer

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2010 Jan 30
PMID 20110884
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

To obtain an aptamer with a high affinity for vascular endothelial growth factor (VEGF), we focused on the receptor-binding domain (RBD) of VEGF as a target epitope. Three rounds of screening gave Vap7, which bound to the VEGF isoforms VEGF(121) and VEGF(165) with K(D) values of 1.0 nM and 20 nM, respectively. Moreover, Vap7 showed specificity within the VEGF family. Secondary structure predictions and circular dicrhoism suggested that Vap7 folds into a G-quadruplex structure. We obtained a mutant aptamer that contains only this region of the aptamer sequence. This truncated mutant (V7t1) bound to both VEGF(121) and VEGF(165) with K(D) values of 1.1 nM and 1.4 nM, respectively. Its sequence was 5'-TGTGGGGGTGGACGGGCCGGGTAGA-3', and it appeared to form a G-quadruplex structure. We also produced an aptamer heterodimer consisting of our previously derived aptamer (del5-1), which binds to the heparin-binding domain of VEGF, linked to V7t1. The resulting heterodimer bound strongly to VEGF(165) with a K(D) value of 4.7 x 10(2) pM.

Citing Articles

Gold Nanoprism Enhanced SERS Aptasensor for Simultaneous Detection of Thrombin and VEGF.

Anantha P, Raj P, Zheng P, Tanwar S, Barman I Sens Actuators B Chem. 2025; 423.

PMID: 39744119 PMC: 11687365. DOI: 10.1016/j.snb.2024.136811.


Systematic design and evaluation of aptamers for VEGF and PlGF biomarkers of Preeclampsia.

Mallawarachchi S, Cebecioglu R, Althumayri M, Beker L, Fernando S, Koydemir H BMC Biotechnol. 2024; 24(1):64.

PMID: 39334133 PMC: 11428563. DOI: 10.1186/s12896-024-00891-0.


Targeted degradation of VEGF with bispecific aptamer-based LYTACs ameliorates pathological retinal angiogenesis.

Zhou P, Zhang S, Li L, Zhang R, Guo G, Zhang Y Theranostics. 2024; 14(13):4983-5000.

PMID: 39267779 PMC: 11388081. DOI: 10.7150/thno.98467.


An Ensemble Docking Approach for Analyzing and Designing Aptamer Heterodimers Targeting VEGF.

Go Y, Kalathingal M, Rhee Y Int J Mol Sci. 2024; 25(7).

PMID: 38612876 PMC: 11012306. DOI: 10.3390/ijms25074066.


Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity.

Yang M, Li C, Ye G, Shen C, Shi H, Zhong L Signal Transduct Target Ther. 2024; 9(1):40.

PMID: 38355661 PMC: 10866937. DOI: 10.1038/s41392-024-01748-w.


References
1.
Hirao I, Madin K, Endo Y, Yokoyama S, Ellington A . RNA aptamers that bind to and inhibit the ribosome-inactivating protein, pepocin. J Biol Chem. 2000; 275(7):4943-8. DOI: 10.1074/jbc.275.7.4943. View

2.
Potty A, Kourentzi K, Fang H, Jackson G, Zhang X, Legge G . Biophysical characterization of DNA aptamer interactions with vascular endothelial growth factor. Biopolymers. 2008; 91(2):145-56. DOI: 10.1002/bip.21097. View

3.
Ikebukuro K, Kiyohara C, Sode K . Novel electrochemical sensor system for protein using the aptamers in sandwich manner. Biosens Bioelectron. 2005; 20(10):2168-72. DOI: 10.1016/j.bios.2004.09.002. View

4.
Tuerk C, Gold L . Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990; 249(4968):505-10. DOI: 10.1126/science.2200121. View

5.
Jayapal P, Mayer G, Heckel A, Wennmohs F . Structure-activity relationships of a caged thrombin binding DNA aptamer: insight gained from molecular dynamics simulation studies. J Struct Biol. 2009; 166(3):241-50. DOI: 10.1016/j.jsb.2009.01.010. View